130 related articles for article (PubMed ID: 24832370)
1. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
Savickiene J; Treigyte G; Stirblyte I; Valiuliene G; Navakauskiene R
Leuk Res; 2014 Jul; 38(7):822-9. PubMed ID: 24832370
[TBL] [Abstract][Full Text] [Related]
2. IVMBIX-01294, an inhibitor of the histone methyltransferase EHMT2, disrupts histone H3 lysine 9 (H3K9) dimethylation in the cleavage-stage porcine embryo.
Park KE; Johnson CM; Cabot RA
Reprod Fertil Dev; 2012; 24(6):813-21. PubMed ID: 22781932
[TBL] [Abstract][Full Text] [Related]
3. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
[TBL] [Abstract][Full Text] [Related]
4. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
[TBL] [Abstract][Full Text] [Related]
5. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells.
Wojtala M; Macierzyńska-Piotrowska E; Rybaczek D; Pirola L; Balcerczyk A
Pharmacol Res; 2018 Feb; 128():252-263. PubMed ID: 29113759
[TBL] [Abstract][Full Text] [Related]
7. Effects of histone deacetylase inhibitors, sodium phenyl butyrate and vitamin B3, in combination with retinoic acid on granulocytic differentiation of human promyelocytic leukemia HL-60 cells.
Merzvinskyte R; Treigyte G; Savickiene J; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2006 Dec; 1091():356-67. PubMed ID: 17341628
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation.
Savickiene J; Treigyte G; Borutinskaite V; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2006 Dec; 1091():368-84. PubMed ID: 17341629
[TBL] [Abstract][Full Text] [Related]
9. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F
Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364
[TBL] [Abstract][Full Text] [Related]
10. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
[TBL] [Abstract][Full Text] [Related]
11. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
[TBL] [Abstract][Full Text] [Related]
13. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
15. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Yokoyama A
Leukemia; 2008 Dec; 22(12):2159-68. PubMed ID: 18784743
[TBL] [Abstract][Full Text] [Related]
16. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.
Coradini D; Pellizzaro C; Scarlata I; Zorzet S; Garrovo C; Abolafio G; Speranza A; Fedeli M; Cantoni S; Sava G; Daidone MG; Perbellini A
Leukemia; 2006 May; 20(5):785-92. PubMed ID: 16525489
[TBL] [Abstract][Full Text] [Related]
17. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.
Savickiene J; Treigyte G; Jonusiene V; Bruzaite R; Borutinskaite VV; Navakauskiene R
Mol Cell Biochem; 2012 Jan; 359(1-2):245-61. PubMed ID: 21842375
[TBL] [Abstract][Full Text] [Related]
19. Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activity.
Rotili D; Tarantino D; Marrocco B; Gros C; Masson V; Poughon V; Ausseil F; Chang Y; Labella D; Cosconati S; Di Maro S; Novellino E; Schnekenburger M; Grandjenette C; Bouvy C; Diederich M; Cheng X; Arimondo PB; Mai A
PLoS One; 2014; 9(5):e96941. PubMed ID: 24810902
[TBL] [Abstract][Full Text] [Related]
20. [A study on the cell differentiation induced by tanshinone IIA and its molecular mechanism in retinoic acid: resistant acute promyelocytic leukemia].
Liang Y; Song WX; Wang J; Jing LP; Qu W; Fu R; Wu XZ
Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):366-9. PubMed ID: 16009009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
